High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis.
about
Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosisAn assessment of the comparative utility of functional and molecular level analyses in the investigation of patients with thrombophiliaEvaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population.Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.Cerebrovascular disorders in children with the factor V Leiden mutation.Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations.Prevalence of factor V Leiden in a Canadian blood donor populationEpidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.Evaluation of chromosomal abnormalities and common trombophilic mutations in cases with recurrent miscarriage.Genetic risk factors in patients with deep venous thrombosis, a retrospective case control study on Iranian populationGuidelines for the management of thrombophilia. Department of Haematology, The Royal London Hospital, Whitechapel, London, UKActivated protein C and retinal vein occlusion.Monocytes, but not endothelial cells, downregulate the anticoagulant activity of activated protein C.Postmortem diagnosis of Factor V Leiden from paraffin wax embedded tissue.Amplification of PCR products in excess of 600 base pairs using DNA extracted from decalcified, paraffin wax embedded bone marrow trephine biopsies.Detection of a common mutation in factor V gene responsible for resistance to activate protein C causing predisposition to thrombosis.Factor V Leiden mutation does not account for central venous catheter-related thrombosis.Resistance to activated protein C in unselected patients with arterial and venous thrombosis.Recurrent abortions in Asian Indians: no role of factor V Leiden Hong Kong/Cambridge mutation and MTHFR polymorphism.Hereditary Thrombophilic Disease Associated with Defects in the Protein C Anticoagulant System.A common polymorphism in the tumour necrosis factor-alpha gene associated with high TNF levels is not a risk factor for venous thromboembolism.Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage.Candidate gene study of genetic thrombophilic polymorphisms in pre-eclampsia and recurrent pregnancy loss in Sinhalese women.Genotype distribution of the mutations in the coagulation factor V gene in the Korean population: Absence of its association with coronary artery diseaseMolecular Genetics of Factor V Leiden: Genetic Origins and Modern DNA-Based Detection Strategies
P2860
Q33618227-AFF33568-0FF6-462E-A8EF-35746BE9AA5AQ33841402-351467C4-17F0-4B8C-9AA0-7C22264FDA3CQ34176440-277B5EEE-C171-4203-B0F3-80E06164D6BDQ34305158-B40AE9DD-152C-4D02-A25E-DC00D6AE87B4Q34415810-5B1FEAFE-A1E6-4EB6-88A0-3B8196CCA378Q34450894-B7F6C4B8-6E70-4A8F-A62F-C86F49E53DE7Q34712722-EEA38E23-EF0A-40B8-B95C-8EE81A75B8B5Q35654066-654069E7-BA39-464D-A9F6-D82238860A9DQ35665231-5BFB795C-083B-4159-B373-1D86088A18E1Q36267584-5EEF03B2-F818-42C8-B392-8BA3039A8939Q36680560-F71113ED-369A-44A6-8AD4-5A05D32EE831Q37318672-3B7ED471-CCE3-4060-B19C-3DF4DE3B91E0Q40828865-6B7F83C3-4B3E-4D05-93E0-6FAF67507DAAQ40849379-CEEF2A7C-6266-4B00-B073-83CDD85B4D74Q41899868-FD85326F-B24D-4345-A4D0-18F85FD0B2DAQ45108556-33082E43-2D40-4679-BE9B-0C1A9D6FEF1BQ45111910-74B0A064-5066-451F-8536-CD9293089918Q45882491-9D1D559B-128A-47E0-90A1-FC0290391DBBQ46832268-7E916FFB-9EF1-4C6E-A496-0E63E803E227Q47683800-B33D895F-DC61-439D-A443-7F6EC0EF4097Q47951287-8E98517D-9B3C-4364-AFCD-6061EF492582Q54011178-BF9B46D5-CD44-4B64-BA9F-679B84001872Q54312552-87C2EC94-AD7F-4D9A-B986-BC9723FE4FF6Q58181924-741CAE9B-CF6F-403F-B1F6-159DCF6838DBQ58624438-9EC1BA52-59FC-49BF-A2FB-748AE9FB7A97
P2860
High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
High prevalence of a mutation ...... tance and familial thrombosis.
@en
High prevalence of a mutation ...... tance and familial thrombosis.
@nl
type
label
High prevalence of a mutation ...... tance and familial thrombosis.
@en
High prevalence of a mutation ...... tance and familial thrombosis.
@nl
prefLabel
High prevalence of a mutation ...... tance and familial thrombosis.
@en
High prevalence of a mutation ...... tance and familial thrombosis.
@nl
P2093
P2860
P1476
High prevalence of a mutation ...... tance and familial thrombosis.
@en
P2093
F E Preston
K K Hampton
N J Beauchamp
P C Cooper
P2860
P304
P356
10.1111/J.1365-2141.1994.TB05005.X
P407
P577
1994-09-01T00:00:00Z